Serevent Side Effects Lawsuit News

11/28/2007 - U.S. regulatory advisers on Wednesday are mulling whether to beef up warnings on GlaxoSmithKline's asthma drug Serevent following reports of several deaths in patients taking the drug. More>>>

11/28/2007 - Government advisers on Wednesday will consider whether a GlaxoSmithKline asthma drug poses greater risks to children than to adults. More>>>

11/28/2007 - The FDA is recommending to the Pediatric Advisory Committee that a thorough risk-benefit analysis for GlaxoSmithKline’s (GSK) asthma treatment Serevent is warranted as the product may have an unfavorable risk-benefit profile for use in children. More>>>

06/20/2006 - Three asthma inhalers with salmeterol or formoterol may cause 80 percent of U.S. asthma deaths annually, says a new study. Because of the possible health risks, these products -- sold as GlaxoSmithKline's Serevent and Advair, and Novartis' Foradil -- should be recalled, said researchers at Cornell University and Stanford University. More >>>

06/19/2006 - Researchers from Stanford and Cornell Universities are recommending three asthma inhalers be pulled from the U.S. market. Four out of five U.S. asthma-related deaths per year may be caused by inhalers containing the drugs salmeterol or formoterol.  The researchers base their conclusions on 19 published studies involving 33,826 patients.  There statistical analysis found that the patients who inhaled the long-acting beta-agonists salmeterol or formoterol  were 3.5 times more likely to die from asthma and 2.5 times more likely to be hospitalized. More >>>

12/07/2004 - Now That an FDA Official Has Voiced Concerns About A Group of Popular Medications, Some Patients Who Take Them Are Seeking Safer Options.
More >>>

11/27/2004 - Concern for drug safety doesn't stop with Vioxx. More >>>

11/19/2004 - FDA Associate director of drug safety recommends recall of 5 drugs. Accutane, Bextra, Meridia, and Serevent. More >>>